Physician

Thomas J Sweeney, MD

According to 2025 Medicare claims, Thomas Sweeney, MD (NPI: 1093711103) practices medical oncology in the Columbus, OH market, with the plurality of this provider's patient population coming from Franklin, OH. This provider's primary affiliated billing organization is COLUMBUS ONCOLOGY ASSOCIATES INC (NPI: 1790875656; TIN: 311211874) and primary practice location at 43214-4359.

Sweeney's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 455 traditional Medicare patients, billed 63,006 HCPCS/CPT codes, and received $1,373,662 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,074 prescription claims across 157 beneficiaries totaling $3,651,876 in drug costs, led by Revlimid (Lenalidomide). DME data shows 54 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $534,014 to $1,373,662. Similarly, Part D prescription costs have risen steadily, from $1,153,177 to $3,651,876. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	425	30,584	$534,014
2016	515	51,858	$790,625
2017	536	70,538	$1,340,736
2018	523	61,279	$1,255,115
2019	497	68,731	$1,292,664
2020	443	60,364	$1,086,006
2021	466	70,757	$1,672,560
2022	500	83,875	$1,788,546
2023	485	86,889	$1,942,054
2024	455	63,006	$1,373,662

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	221	1,332	$1,153,177
2016	208	1,233	$1,281,602
2017	221	1,506	$1,524,349
2018	235	1,509	$1,675,968
2019	208	1,433	$2,127,169
2020	186	1,170	$1,729,338
2021	193	1,145	$1,755,702
2022	182	1,020	$1,861,009
2023	182	1,042	$1,913,948
2024	157	1,074	$3,651,876

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	25	$21,012
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	54	$8,281
2019	N/R	85	$7,031
2020	N/R	34	$4,413
2021	N/R	37	$2,701
2022	N/R	N/R	N/R
2023	N/R	24	$485
2024	N/R	54	$1,943

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	50	79	$131
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	216	640	$90
96413	Administration of chemotherapy into vein, 1 hour or less	57	177	$89
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	146	166	$57
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	141	190	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	72	2,016	$1,478,504
Lenalidomide	Lenalidomide	34	952	$477,466
Inlyta	Axitinib	16	480	$408,205
Brukinsa	Zanubrutinib	17	510	$251,418
Jaypirca	Pirtobrutinib	11	330	$230,643

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	12	$906
E1392	Portable oxygen concentrator, rental	Y	N/R	12	$417
J8530	Cyclophosphamide; oral, 25 mg	N	N/R	15	$357
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	15	$263

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Thomas J. Sweeney, MD?

Tedicare shows public-source Medicare data for Thomas J. Sweeney, MD (NPI 1093711103), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Thomas J. Sweeney, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Thomas J. Sweeney, MD?

Thomas J. Sweeney, MD is linked to COLUMBUS ONCOLOGY ASSOCIATES INC (billing NPI 1790875656) in the available physician profile data.

Does Thomas J. Sweeney, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.